πŸ‡ΊπŸ‡Έ FDA
Patent

US 12083184

Hydrogel prodrug for treatment

granted A61KA61K31/195A61K31/197

Quick answer

US patent 12083184 (Hydrogel prodrug for treatment) held by Viking Scientific, Inc. expires Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Viking Scientific, Inc.
Grant date
Tue Sep 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K31/195, A61K31/197, A61K31/198, A61K31/245